HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ABACUS Study Group Selected Research

ombitasvir

10/2018Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


ABACUS Study Group Research Topics

Disease

1Fibrosis (Cirrhosis)
10/2018
1Hypertension (High Blood Pressure)
10/2018

Drug/Important Bio-Agent (IBA)

1paritaprevirIBA
10/2018
1ombitasvirIBA
10/2018
1dasabuvirIBA
10/2018
1AlbuminsIBA
10/2018
1Ribavirin (Virazole)FDA LinkGeneric
10/2018
1Ritonavir (Norvir)FDA Link
10/2018